Jove
Visualize
Contact Us

Related Concept Videos

Diversity of Protists II01:27

Diversity of Protists II

1.2K
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
1.2K
Diversity of Protists I01:15

Diversity of Protists I

1.3K
Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
1.3K
Diversity of Protists IV01:27

Diversity of Protists IV

1.1K
Amoebozoa represent a diverse group of terrestrial and aquatic protists that utilize lobe-shaped pseudopodia for locomotion and feeding. This characteristic differentiates them from the Rhizaria, which possess threadlike pseudopodia. The primary classifications within Amoebozoa include gymnamoebas, entamoebas, and the plasmodial and cellular slime molds. Phylogenetic evidence indicates that Amoebozoa diverged from a lineage that ultimately gave rise to fungi and animals.Gymnamoebas and...
1.1K
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

582
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
582
Overview of Protists01:27

Overview of Protists

2.0K
Protists are diverse eukaryotic microorganisms that lack the specialized tissues of plants and animals and the chitinous cell walls of fungi. Their early divergence within Eukarya resulted in structural, functional, and ecological diversity. They are classified into supergroups such as Archaeplastida, Excavata, Amoebozoa, Rhizaria, Alveolata, and Stramenopiles, determined through genetic analysis and structural similarities.Structural and Functional AdaptationsProtists have various adaptations...
2.0K
Diversity of Protists III01:27

Diversity of Protists III

1.1K
Rhizaria are a diverse group of unicellular protists characterized by their threadlike cytoplasmic extensions known as pseudopodia. These structures aid in both locomotion and feeding, giving Rhizaria an amoeboid appearance. Their amoeboid morphology once led to taxonomic confusion, but molecular phylogenetics has clarified their evolutionary placement and emphasized their shared use of pseudopodia despite divergent lineages.This clade comprises diverse lineages such as Chlorarachniophyta,...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-Content SRS Imaging Unveils Altered Cholesterol Metabolism in Ovarian Cancers Under CAR-T Treatment.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

What do you most hope we will achieve with mammalian synthetic biology within the next decade?

Cell systems·2025
Same author

Cholesterol metabolism modulation facilitates CAR-T induced killing of ovarian cancer.

bioRxiv : the preprint server for biology·2025
Same author

Reticulocyte Binding Protein Homologue 5 is a target of balancing selection in the <i>Plasmodium falciparum</i> population of Papua New Guinea.

Frontiers in parasitology·2025
Same author

A Pilot Survey of Patient Perspectives on an Artificial Intelligence-Generated Presenter in a Patient Information Video about Face-Down Positioning after Vitreoretinal Surgery.

Ophthalmic research·2024
Same author

IKKɛ induces STING non-IFN immune responses via a mechanism analogous to TBK1.

iScience·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 19, 2026

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
09:13

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

1.9K

A Weak Spot in Multiple Protozoan Parasites.

Wilson Wong1

  • 1Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.

Structure (London, England : 1993)
|November 9, 2017
PubMed
Summary

Researchers identified quinazolinone derivatives as potential drugs to combat parasitic infections like malaria and leishmaniasis. These compounds target the essential parasitic enzyme prolyl-tRNA synthetase, offering a new therapeutic strategy.

More Related Videos

Studying Inherited Immunity in a Caenorhabditis elegans Model of Microsporidia Infection
09:24

Studying Inherited Immunity in a Caenorhabditis elegans Model of Microsporidia Infection

Published on: April 6, 2022

2.8K
Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
13:54

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Published on: April 2, 2013

10.9K

Related Experiment Videos

Last Updated: Feb 19, 2026

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
09:13

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases

Published on: November 22, 2024

1.9K
Studying Inherited Immunity in a Caenorhabditis elegans Model of Microsporidia Infection
09:24

Studying Inherited Immunity in a Caenorhabditis elegans Model of Microsporidia Infection

Published on: April 6, 2022

2.8K
Tractable Mammalian Cell Infections with Protozoan-primed Bacteria
13:54

Tractable Mammalian Cell Infections with Protozoan-primed Bacteria

Published on: April 2, 2013

10.9K

Area of Science:

  • Parasitology
  • Medicinal Chemistry
  • Structural Biology

Background:

  • Eukaryotic protozoan parasites cause diseases such as malaria, toxoplasmosis, and leishmaniasis, leading to substantial human mortality.
  • The development of novel therapeutic agents against these diverse parasites remains a critical global health challenge.

Purpose of the Study:

  • To identify and characterize novel drug candidates targeting parasitic infections.
  • To investigate the potential of quinazolinone-based derivatives against parasitic prolyl-tRNA synthetase.

Main Methods:

  • Structure-based drug design.
  • Enzyme inhibition assays.
  • Antiparasitic activity screening.

Main Results:

  • Identification of a series of quinazolinone derivatives with potent activity.
  • Demonstration that these derivatives target the parasitic prolyl-tRNA synthetase enzyme.
  • Evidence of broad-spectrum antiparasitic activity against diverse protozoan parasites.

Conclusions:

  • Quinazolinone derivatives targeting parasitic prolyl-tRNA synthetase represent a promising class of compounds for treating protozoan parasitic infections.
  • Further development of these compounds could lead to new treatments for malaria, toxoplasmosis, and leishmaniasis.